Indivior (INDV) Anderson Woodrow D, Chief Accounting Officer Buys 1,500 Shares

What Happened
Anderson Woodrow D, Chief Accounting Officer of Indivior Pharmaceuticals (INDV), acquired 1,500 shares in a purchase reported on 2026-08-27. The filing shows an acquisition price of $35.69 per share for a total cash outlay of $53,535. The form lists the trade type as an open market or private purchase (code P), indicating a direct buy rather than a grant or exercise.

Key Details

• Transaction date: 2026-08-27
• Price per share: $35.69; Total value: $53,535
• Transaction code: P (Purchase) — described as "open market or private purchase" in the filing
• Shares owned after transaction: Not specified in the filing
• Footnotes/plan info: Filing does not disclose a 10b5‑1 plan or other special footnotes
• Timeliness: Report filed on 2026-08-27 (period of report 2026-08-27); filing does not indicate a late report

Context
This was an outright purchase by a company officer — purchases by insiders can be interpreted by investors as a sign of confidence but do not prove future performance. The filing provides no indication this insider is a 10% owner, and no derivatives, option exercises, gifts, or tax-withholding events were reported in this transaction.